Management Team

Manijeh Goldberg, Ph.D., M.B.A., M.S. -- Chief Executive Officer

Manijeh is the Founder and CEO of Privo. She has over 20 years of experience in the biomedical industry, in large companies and five startups (one was acquired for $275M). She holds a PhD in Biomedical Engineering, an MS in Biomedical Enterprise from Harvard Medical School, an MBA from MIT, and an MS in Computer Science and Mathematics.


Ellen Milano -- VP of Regulatory

Ellen Milano is President of Milano Regulatory Solutions, Inc. She brings more than 40 years of extensive experience in both Regulatory Affairs as well as pharmaceutical technical issues. Her broad knowledge of the FDA-regulated industry spans the drug sector, and includes both pre-and post-approval stages of development. She has expertise in product development, regulatory affairs, analytical development, QA/QC and compliance, QSR and PAI and diverse FDA submissions (CMC sections of INDs and NDAs; ANDAs; DMFs, Supplements and Amendments).


Steven Goldberg, M.B.A. -- Chief Financial Officer

Steven serves as the Chief Financial Officer to Privo. He has worked as an executive in multiple industries with over 30 years of successful fundraising experience with expertise in modeling financial scenarios. He holds an MBA from Colombia University and BA from Tufts University.


Bill Riffert, B.S. -- Vice President of Business Development

Bill Riffert is a leading industry executive with in depth experience in building long term mutually beneficial strategic partnerships. With over 20 years of international success working in high value sales, technology, and business development, Bill has proven his skills in bringing together technology and client needs to produce expert solutions.